Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory disease that may affect peripheral and axial joints, entheses, skin and nails, and other organs. Treatment with nonsteroidal anti-inflammatory drugs, steroid and disease-modifying antirheumatic drugs had been the backbone of traditional management of PsA for many years. However, improvement in our understanding of immunopathogenesis of PsA has led to new immunomodulatory therapies. Introduction of novel agents has raised the bar for treatment and helped drive research into additional therapeutic options. © 2015, SAGE Publications. All rights reserved.
CITATION STYLE
Kang, E. J., & Kavanaugh, A. (2015). Psoriatic arthritis: Latest treatments and their place in therapy. Therapeutic Advances in Chronic Disease. https://doi.org/10.1177/2040622315582354
Mendeley helps you to discover research relevant for your work.